Pharmatest has provided assistance for almost a hundred pharmaceutical, biotechnology and nutraceutical companies worldwide in their efficacy research. Most of our customers come to us before their candidates enter official pipelines and therefore wish to remain undisclosed. Therefore, we do not disclose any of our customers unless they specifically agree.
Below you can find some testimonials of our customers who have been satisfied with the quality of our services.
Selected customer testimonials
Dr. Karl ZiegelbauerSVP Therapeutic Research Groups, Pharmaceuticals Division, Bayer Pharma AG, Germany
"Bayer has worked for several years with Pharmatest and we are very impressed about the high quality of the work they have done for us."
Dr. Dana T. AftabExecutive Vice President, Business Operations, Exelixis Inc., USA
"Exelixis has been working with Pharmatest since 2011, and we have been very pleased with their excellent data quality, detailed and thorough reports, and highly professional and knowledgeable staff.”
Dr. Leslie HolsingerVice President of Biology, Virobay Inc., USA
"Virobay has worked with Pharmatest on both in vitro and in vivo model analysis of drug candidates and we are very pleased with the excellent quality of their work and the high level of scientific expertise they provide to our studies.”
Dr. Pekka KallioHead of Oncology Research, Orion Oyj, Finland
“Orion started to use services of Pharmatest more than 10 years ago, and we are happy about the excellent scientific quality of their work and reporting.”
Dr. Nick FlinnHead of Pre-clinical Development, Amura Therapeutics, England
"Amura has worked closely with Pharmatest for over a decade in the areas of bone turnover and bone metastases. Pharmatest has provided support and advice in addition to a first class in vitro and in vivo screening service for the analysis and progression of Amura's drug candidates. We are always impressed with the excellent quality of their work and the high level of scientific expertise they provide to our studies.”
Dr. Hubert ChenChief Medical Officer, Pfenex Inc., USA
“It was a great pleasure working with Pharmatest. The scientific expertise and advice offered by the Pharmatest team were top notch. There was excellent, proactive communication from the very beginning of the project, which finished on time and within budget. I have no hesitations in recommending Pharmatest as a high-quality CRO for preclinical services in skeletal diseases.”
Dr. Satu VainikkaCEO, Valirx Plc, UK
"Pharmatest has been our preferred supplier of preclinical proof-of-concept studies for some time now and we are very satisfied about the high quality and scientific expertise that they provide."
Hanne Heidenheim BakM.Sc. Pharm, Senior Project Director, Head of Project Management, Zealand Pharma A/S, Denmark
"It has been a pleasure working with the Pharmatest team. You have been an excellent communicator, always informing us promptly on changes or questions that have come up and providing great feedback to our questions. We certainly experience Pharmatest as a very competent company with very professional employees."
Dr. Jean-Baptiste MarchandHead of Proteins Science Group, Transgene, France
”Transgene and Pharmatest have successfully collaborated since 2009 for the in vitro and in vivo preclinical evaluation of TG’s monoclonal platform in different skeletal diseases. Transgene was particularly impressed by the high professionalism of Pharmatest’s scientist staff, who participated actively nearby our teams in the designs, execution and analysis of the experiments.”
Headquarters, Research laboratories
Pharmatest Services Itäinen Pitkäkatu 4 A, 5th floor 20520 Turku FINLAND
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.